Instellingen beheren
MENU
Over deze site
In English
Home
Onderzoekers
Projecten
Organisaties
Publicaties
Infrastructuur
Contact
Research Explorer
Uw browser ondersteunt geen JavaScript of JavaScript is niet ingeschakeld. Zonder JavaScript kan sommige functionaliteit van deze webapplicatie uitgeschakeld zijn of foutmeldingen veroorzaken. Raadpleeg om JavaScript in te schakelen de handleiding van uw browser of contacteer uw systeembeheerder.
Onderzoeker
Sarah Dewilde
Profiel
Projecten
Publicaties
Activiteiten
Prijzen & Erkenningen
37
Resultaten
2019
New insights in the costs and quality of life of patients after ischemic stroke : implications for heath care policy
Sarah Dewilde
Lieven Annemans
Vincent Thijs
Proefschrift
2019
2018
Hospital financing of ischaemic stroke : determinants of funding and usefulness of DRG subcategories based on severity of illness
Sarah Dewilde
Lieven Annemans
Hilde Pincé
Vincent Thijs
A1
Artikel in een tijdschrift
in
BMC HEALTH SERVICES RESEARCH
2018
What impact does venous thromboembolism and bleeding have on cancer patients' quality of life?
Andrew J Lloyd
Sarah Dewilde
Simon Noble
Elisabeth Reimer
Agnes YY Lee
A1
Artikel in een tijdschrift
in
VALUE IN HEALTH
2018
2017
Health state utilities in non-small cell lung cancer : an international study
Beenish Nafees
Andrew J Lloyd
Sarah Dewilde
Narayan Rajan
Maria Lorenzo
A1
Artikel in een tijdschrift
in
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY
2017
2016
The impact of cancer-associated thrombosis and treatment related bleedings on patients' quality of life
S Noble
AJ Lloyd
Sarah Dewilde
E Reimer
A Lee
C3
Conferentie
2016
2015
Analysis of in-hospital resource use after an ischemic stroke
Sarah Dewilde
Lieven Annemans
V Thijs
C3
Conferentie
2015
Analysis of primary and secondary APR-DRG codes of an ischemic stroke admission
Sarah Dewilde
Lieven Annemans
V Thijs
C3
Conferentie
2015
Investigating the relationship between 'Severity Of Illness' and the 'Modified Rankin Scale' in ischemic stroke patients with response mapping
Sarah Dewilde
Lieven Annemans
V Thijs
C3
Conferentie
2015
Quality of life of patients experiencing cancer-associated thrombosis
Sarah Dewilde
AJ Lloyd
MV Holm
AY Lee
C3
Conferentie
2015
2014
Place of residence and employment status after stroke
Sarah Dewilde
A Peeters
V Thijs
Lieven Annemans
C3
Conferentie
2014
Quality of life decrements after stroke
Sarah Dewilde
V Thijs
Lieven Annemans
A Peeters
C3
Conferentie
2014
Utilities for treatment-related adverse events in type 2 diabetes
S Shingler
B Fordham
M Evans
M Schroeder
G Thompson
Sarah Dewilde
AJ Lloyd
A1
Artikel in een tijdschrift
in
JOURNAL OF MEDICAL ECONOMICS
2014
2013
Cost-effectiveness of bendamustine-rituximab in first-line indolent NHL : a patient-level simulation
Sarah Dewilde
B Woods
JG Castaigne
C Parker
W Dunlop
C3
Conferentie
2013
2012
Investigating incoherence gives insight : clopidogrel is equivalent to extended-release dipyridamole plus aspirin in secondary stroke prevention
Sarah Dewilde
Neil Hawkins
A1
Artikel in een tijdschrift
in
JOURNAL OF CLINICAL EPIDEMIOLOGY
2012
Patient preferences for first-line oral treatment for mild-to-moderate ulcerative colitis : a discrete-choice experiment
Paul Hodgkins
Paul Swinburn
Dory Solomon
Linnette Yen
Sarah Dewilde
Andrew Lloyd
A1
Artikel in een tijdschrift
in
PATIENT-PATIENT CENTERED OUTCOMES RESEARCH
2012
2011
Cost of hospitalization for cerebrovascular disorders in Belgium
Vincent Thijs
Sarah Dewilde
Koen Putman
Hile Pincé
A1
Artikel in een tijdschrift
in
ACTA NEUROLOGICA BELGICA
2011
Cost-effectiveness of adjunctive eptifibatide in patients undergoing coronary stenting in Germany
Sarah Dewilde
Bernd Brüggenjürgen
Christoph Nienaber
Jochen Senges
Robert Welte
Stefan N Willich
A1
Artikel in een tijdschrift
in
EUROPEAN JOURNAL OF HEALTH ECONOMICS
2011
2009
Cost-effectiveness of warfarin : trial versus 'real-world' stroke prevention in atrial fibrillation
Sonja V Sorensen
Sarah Dewilde
Daniel E Singer
Samuel Z Goldhaber
Brigitta U Monz
Jonathan M Plumb
A1
Artikel in een tijdschrift
in
AMERICAN HEART JOURNAL
2009
Cost-effectiveness of ziconotide in intrathecal pain management for severe chronic pain patients in the UK
Sarah Dewilde
L Verdian
GDH MacLaine
A1
Artikel in een tijdschrift
in
CURRENT MEDICAL RESEARCH AND OPINION
2009
Eliciting health state utilities from the general public for severe chronic pain
S Eldabe
A Lloyd
L Verdian
M Meguro
G Maclaine
Sarah Dewilde
A1
Artikel in een tijdschrift
in
EUROPEAN JOURNAL OF HEALTH ECONOMICS
2009
The efficacy of clopidogrel versus the combination of low dose aspirin plus extended-release dipyridamole in preventing serious vascular events : a network meta-analysis
Sarah Dewilde
J Eaton
NS Hawkins
C3
Conferentie
2009
2007
Cost-effectiveness of sunitinib as second line treatment in patients with metastatic renal cancer in Belgium
Floortje van Nooten
Sarah Dewilde
Simon Van Belle
Sophie Marbaix
C3
Conferentie
2007
Eliciting patient preferences for hormonal therapy options in the treatment of metastatic prostate cancer
A Lloyd
D Penson
Sarah Dewilde
L Kleinman
A1
Artikel in een tijdschrift
in
PROSTATE CANCER AND PROSTATIC DISEASES
2007
Eliciting utility scores for health states associated with severe chronic pain
Andrew Lloyd
M Meguro
Sarah Dewilde
Grant MacLaine
Lara Verdian
C3
Conferentie
2007
Preferences and utilities for the symptoms of moderate to severe allergic asthma
Andrew Lloyd
Scott Doyle
Sarah Dewilde
Florian Turk
A1
Artikel in een tijdschrift
in
EUROPEAN JOURNAL OF HEALTH ECONOMICS
2007
2006
Cost-effectiveness of eptifibatide in patients undergoing percutaneous coronary intervention in Germany
Sarah Dewilde
B Bruggenjurgen
R Welte
SN Willich
C3
Conferentie
2006
Health state utilities for metastatic breast cancer
A Lloyd
B Nafees
J Narewska
Sarah Dewilde
J Watkins
A1
Artikel in een tijdschrift
in
BRITISH JOURNAL OF CANCER
2006
Impact of omalizumab on quality-of-life outcomes in patients with moderate-to-severe allergic asthma
Kimberly Niebauer
Sarah Dewilde
Julia Fox-Rushby
Dennis A Revicki
A1
Artikel in een tijdschrift
in
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY
2006
Relapsing-remitting multiple sclerosis (RR-MS) patients' valuation of MS treatment benefits
J Narewska
A Lloyd
Sarah Dewilde
SL Hass
DW Miller
C3
Conferentie
2006
The economic value of anti-IgE in severe persistent, IgE-mediated (allergic) asthma patients : adaptation of INNOVATE to Sweden
Sarah Dewilde
F Turk
M Tambour
T Sandström
A1
Artikel in een tijdschrift
in
CURRENT MEDICAL RESEARCH AND OPINION
2006
2005
Cost-effectiveness of eptifibatide in NSTEMI patients in Poland
Sarah Dewilde
G Opolski
R Brown
C3
Conferentie
2005
The cost of asthma exacerbations of different severity levels
Sarah Dewilde
G Rapatz
F Turk
C3
Conferentie
2005
The effect of anticoagulation for stroke prevention in patients with atrial fibrillation comparing efficacy and effectiveness
Sarah Dewilde
SV Sorensen
R Brown
BU Monz
C3
Conferentie
2005
2004
The cost-effectiveness of screening programs using single and multiple birth cohort simulations : a comparison using a model of cervical cancer
Sarah Dewilde
Rob Anderson
A1
Artikel in een tijdschrift
in
MEDICAL DECISION MAKING
2004
The perceived benefits of dosing schedules for children with ADHD
M Price
A Lloyd
C Yuen
Sarah Dewilde
Lieven Annemans
D Coghill
C3
Conferentie
2004
2003
Establishing the cost-effectiveness of statins in the primary prevention of CHD using a quasi Markov model
Sarah Dewilde
A Davies
J Hutton
C3
Conferentie
2003
The cost-effectiveness of screening programs using single and multiple birth cohort simulations : a comparison using a model of cervical cancer
Sarah Dewilde
R Anderson
C3
Conferentie
2003